Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
about
Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphismDose-Dependent Changes in Auditory Sensory Gating in the Prefrontal Cortex of the Cynomolgus Monkey.Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometryMice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalonThe moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.Meclizine enhancement of sensorimotor gating in healthy male subjects with high startle responses and low prepulse inhibition.SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine.Deletion of striatal adenosine A(2A) receptor spares latent inhibition and prepulse inhibition but impairs active avoidance learningP50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatmentThe effect of pregabalin on sensorimotor gating in 'low' gating humans and mice.Prepulse inhibition in HIV-associated neurocognitive disorders.Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.Adenosine augmentation ameliorates psychotic and cognitive endophenotypes of schizophrenia.The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males.Lack of relationship between acoustic startle and cognitive variables in schizophrenia and control subjectsSensorimotor gating of schizophrenia patients depends on Catechol O-methyltransferase Val158Met polymorphismPrepulse inhibition and genetic mouse models of schizophrenia.Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.Effect of apomorphine on cognitive performance and sensorimotor gating in humansThe effects of memantine on prepulse inhibition.Short-term selective breeding for high and low prepulse inhibition of the acoustic startle response; pharmacological characterization and QTL mapping in the selected linesPramipexole effects on startle gating in rats and normal menDeveloping translational animal models for symptoms of schizophrenia or bipolar maniaAmphetamine effects on startle gating in normal women and female rats.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.Cognitive and prepulse inhibition deficits in psychometrically high schizotypal subjects in the general population: relevance to schizophrenia research.Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels.Prepulse inhibition in euthymic bipolar disorder patients in comparison with control subjects.Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.Clonidine normalizes levels of P50 gating in patients with schizophrenia on stable medication.Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol.Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism.Individual difference in prepulse inhibition does not predict spatial learning and memory performance in C57BL/6 mice.Loss-of-function mutation in Mirta22/Emc10 rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion.
P2860
Q24645703-F7CCBADD-06F2-48A9-8291-59E9B65A60FBQ28282922-832C2E8E-9319-4E22-B5DD-19677AAD0C84Q30378932-B7D6CD02-625A-4F6A-8CA4-0FACF2B26304Q30397569-9E3DEF67-AA87-4880-A46B-815D3DA943ECQ30404054-B594F03C-3CE9-454E-95D9-BF4A3809A03FQ30404423-4560A075-A36C-42AE-AB9E-94DEF6E70871Q30404784-B786C871-5B49-4FA8-B5E5-182B2DA9C389Q30419962-D5A96FE0-A723-4CCE-AEAE-3336D944606EQ30427289-156D6C44-71BF-422D-9123-2DE9FDB60358Q30440698-290984B7-BBFF-46D8-ACED-A400B6A4DBCFQ30442472-848AE84C-4560-47FD-9811-258116247D6DQ30450055-C59769E2-563D-40D8-B743-525FB1D09140Q30451688-B11D92C7-59DA-4739-8F75-67F7FC347BE7Q30458053-D23633EB-BED4-461D-9A96-3D8A9EE993F2Q30459497-AAAFBA64-9452-4D09-BC72-46987B9292E5Q30466024-89656BB8-B317-4347-B51E-BF008F3C4ECEQ30466238-7BEF2EDF-03FB-4BBF-A35E-DC53EC428C2EQ30467332-FB521DC4-AAB8-4E6C-9EA2-617493DAE7DEQ30476817-28B8BA61-D18B-442D-81BD-B3988ECD5EEBQ30478270-C285DF9B-C211-441F-A3EF-4E3E5A00785BQ30484437-992D055E-B75F-4E86-A9C1-00CF71B685E7Q30484813-8FA1CFCF-1272-4947-94B2-42079004D439Q30485038-27D11EC8-2F7D-4331-98A4-BC8DC73F9C09Q30486395-05E4B03C-BABE-4560-ABE2-17BB28BED5C8Q30487682-37BC4F20-7CA1-4FBE-86B4-98FF66A80A58Q30487857-09C679C0-B9D4-4654-B782-FC9B4618FC5CQ30487988-88CDC8F8-2490-4240-A9E4-3B27C5CFDCEAQ30489404-82AF70A7-9D71-4D17-8B5A-66484207CC1AQ30491461-047C0BBF-4969-4B7D-9B34-BD462BC0FCE5Q34279073-A5FD0E75-2517-4C35-A6A4-F6D2A4FA639DQ38011879-E9C9DB4B-1A1F-4C66-91BF-8B2220AC995BQ38177652-3C1206BF-309E-45A0-A8A3-7618AA3943A9Q39652829-295B9947-7FAF-4282-8154-86C351A098C1Q39688706-381E8246-E8A6-41C0-AEB0-F27734200DD5Q42010840-C7219A31-6FE2-4ABE-80D7-E191CAA3954AQ42219614-24AABF7A-A805-41B1-809A-8F1379AC2F84Q42361149-6D49C8A0-736B-4143-B619-6751FA5D9E8CQ46763660-BF603F30-E54F-4106-AA39-132E5BAEF0BBQ47659102-CCF40172-0D03-4985-BC73-07B31F435DB4Q47787615-7A09AF46-6EE2-40DF-A683-5D3C5D97434F
P2860
Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Haloperidol differentially mod ...... or low and high gating levels.
@en
Haloperidol differentially mod ...... or low and high gating levels.
@nl
type
label
Haloperidol differentially mod ...... or low and high gating levels.
@en
Haloperidol differentially mod ...... or low and high gating levels.
@nl
prefLabel
Haloperidol differentially mod ...... or low and high gating levels.
@en
Haloperidol differentially mod ...... or low and high gating levels.
@nl
P2093
P2860
P356
P1476
Haloperidol differentially mod ...... or low and high gating levels.
@en
P2093
Benjamin K Yee
Franz X Vollenweider
Joram Feldon
Mark A Geyer
Philipp A Csomor
Renée R Stadler
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301421
P407
P577
2007-04-25T00:00:00Z